CPT-1 deficiency is a AR disorder characterized by an increased risk of hypoglycemia, liver failure, hepatic encephalopathy and hyperammonaemia, particularly during periods of fasting or illness (73). This evidence concerns the gene CPT1A and Hypoglycemia.